(Image: MIT News)

The human brain is one of the most complex systems in the world, containing billions of neurons that communicate with one another to control movement, memory, emotions, learning, and decision-making. Neurons are specialized cells that receive, process, and transmit information throughout the nervous system. As technology continues to advance, scientists have begun developing artificial neurons, which are electronic or computational systems designed to initiate some of the functions of biological neurons. Artificial neurons have the potential to change how humans interact with technology and could contribute to advancements in artificial intelligence, medicine, and brain-computer interfaces. 

Biological neurons communicate by receiving electrical and chemical signals from other cells. When a neuron receives enough stimulation, it produces an electrical signal called an action potential, which travels along the neuron and allows it to communicate with other neurons. Artificial neurons attempt to replicate this process using electronic components or mathematical models. Instead of relying on biological structures, they use circuits, processors, or algorithms to receive information, process it, and produce an output. This allows artificial neurons to mimic certain aspects of how biological neurons respond to information.

One of the most common examples of an artificial neuron can be found in artificial neural networks, which are an important component of modern artificial intelligence. In these systems, artificial neurons are organized into interconnected layers. Each artificial neuron receives information, assigns different levels of importance to that information, and produces an output. By connecting thousands or even millions of these artificial neurons, computers can recognize patterns such as image recognition, speech recognition, recommendation systems, and language processing.

Artificial neurons are also being investigated for their potential medical application. Scientists are exploring ways to use artificial neurons to interact with the human nervous system and potentially restore lost or damaged functions. For example, artificial neural systems could one day help individuals with neurological injuries communicate with prosthetic limbs or other assistive technologies. Instead of relying entirely on muscles to control prosthetic devices, signals from the nervous system could potentially be interpreted by an artificial system and translated into movement. This could provide individuals with greater control and independence.

Another important area of research involves brain-computer interfaces. Which are technologies that allow signals from the brain to communicate with an external device. Artificial neurons could potentially help process these complex neural signals and translate them into commands. This could have applications for people who have lost the ability to move or communicate due to neurological conditions or injuries. Although this technology is still developing, researchers are investigating how artificial neural systems can work alongside the human nervous system.

Despite their potential, artificial neurons still face several challenges. Biological neurons are incredibly complex and perform functions that are difficult to reproduce artificially. Scientists must also consider issues such as energy efficiency, compatibility with biological tissue, reliability, and long-term safety when developing artificial neural systems. Creating technology that can accurately interact with the human nervous system requires a detailed understanding of both neuroscience and engineering. 

Overall, artificial neurons represent an important connection between biology and technology. By attempting to reproduce some of the functions of biological neurons, researchers are creating new possibilities in artificial intelligence, medicine, and human-computer interaction. Although artificial neurons cannot yet fully replicate the complexity of the human brain, continued research could allow them to become increasingly sophisticated. In the future, artificial neurons cannot yet fully replicate the complexity of the human brain, continued research could allow them to become increasingly sophisticated. In the future, artificial neurons may play an important role in developing smarter technology and creating new ways to restore or enhance human abilities.  

Works Cited:

Gulen, Kerem. What Is Artificial Neuron: Types and Applications - Dataconomy, 19 Feb. 2025, dataconomy.com/2025/02/19/artificial-neuron/. Accessed 30 Aug. 2026.

McClure, Paul. “Artificial Neuron Melds Electronics and Biology to Function like the Real Thing.” Refractor, 1 Oct. 2025, refractor.io/medical-tech/artificial-neuron-mimic-reality-bioelectronics/. Accessed 30 Aug. 2026.

“What Is an Artificial Neuron and How Does It Work?” Biology Insights, 30 July 2025, biologyinsights.com/what-is-an-artificial-neuron-and-how-does-it-work/#google_vignette. Accessed 30 Aug. 2026.

(Image: Health eCareers)

Surgeons are amongst the highest qualified professions that perform complex procedures that are lengthy and an enduring adventure to better a patient's quality of life. Yet, they still face human limitations when it comes to performing surgery of the smallest anatomical structures. Microsurgical robots enable surgeons to comfortably perform the most challenging microsurgery. Microsurgery robots are specialized robotic systems that help surgeons perform extremely small and precise surgical procedures. They are primarily useful when surgeons need to work on tiny structures such as nerves, blood vessels, or delicate tissues. 

Unlike robots that operate completely on their own run by a program, most microsurgery robots are controlled by a surgeon. A surgeon will look at the surgical area through a microscope or high-resolution camera, and control the robotic instrument using a console with specialized controls. The robot translates the surgeon's movements into much smaller and steadier movements. The robotic instruments manipulate tiny structures that can be difficult to handle with normal surgical tools. For instance, if a surgeon moves their hand 5mm, the robot could translate that into a much smaller movement at the surgical instrument.

The advancement of microsurgery robots has become an important development in the surgical field because of their ability to improve precision and control. One of their greatest advantages is their potential to reduce the effects of natural human limitations during surgery. Human hands can experience small involuntary movements, commonly known as tremors, and surgeons can also experience fatigue during lengthy procedures. When operating on structures that are only a fraction of a millimetre wide, even a very small movement can have significant consequences. Robotic systems can help address these challenges through features such as motion scaling, tremor reduction, and improved instrument control. These capabilities can allow surgeons to perform delicate procedures with greater stability and accuracy. 

Microsurgery robots can be used in several areas of medicine, including nerve repair, blood-vessel reconstruction, reconstructive surgery, and lymphatic surgery. For example, after a serious injury, a surgeon may need to reconnect extremely small blood vessels or nerves to restore function to a damaged area. Robotic assistance can provide the precision needed to carefully reconnect these structures. This can potentially improve recovery and help patients regain movement, sensation, or normal function following surgery.

Despite their advantages, microsurgery robots also have limitations. The technology can be expensive, requires specialized training, and may not be available in every hospital. Surgeons must learn how to operate the robotic systems effectively while still understanding the complexities of human anatomy. As the technology develops, researchers are working to make these systems more accessible, precise, and efficient.

It is important to remember that microsurgery robots are not autonomous robot surgeons and that a surgeon remains responsible for making medical decisions and controlling the procedure. The robot acts more like an ultra-precise extension of the surgeon's hands. By combining human expertise and decision-making with robotic precision, microsurgery robots have the potential to transform microsurgery and make complex procedures safer, more controlled, and more effective in the future.

Works Cited:

Bettens, Hendrikje, et al. Advancements in Robotic Assisted Microsurgery: Exploring the Musa Robot in Reconstructive Microsurgical and Supermicrosurgical Procedures - Sciencedirect, 4 Dec. 2024, www.sciencedirect.com/science/article/pii/S2352587825002803. Accessed 30 Aug. 2026.

“New Surgical Robots Push Precision Past Human Limits.” Nature News, Nature Publishing Group, www.nature.com/articles/d42473-025-00342-0. Accessed 30 Aug. 2026.

“Redefining What’s Possible in Microsurgery: How MMI Brought a Robotic Surgical System to Market in Record Time.” NI, 9 Sept. 2025, www.ni.com/en/perspectives/bringing-robotic-microsurgery-to-market-mmi.html. Accessed 30 Aug. 2026.

(Image: Innovative Genomics Institute)

Scientific discoveries are constantly changing the way we understand and treat disease. One of the most significant developments in modern biotechnology is CRISPR gene editing, a technology that allows scientists to make precise changes to DNA. Since its development CRISPR has transformed genetic research and created new possibilities for treating diseases that were once considered extremely difficult to address. Although the technology is still developing, its potential has made it one of the most important discoveries in modern medicine. 

CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats. The technology is based on a natural defense system found in bacteria, which uses CRISPR-associated proteins to recognize and cut genetic material from invading viruses. Scientists adapted this system into a tool that can identify specific sections of DNA and make targeted changes. One of the most important proteins used in this process is Cas9, an enzyme that can cut DNA at a location selected by researchers.

The basic idea behind CRISPR is relatively simple. Scientists create a guide RNA that directs Cas9 enzymes toward a specific sequence of DNA. Once Cas9 reaches the targeted location, it cuts the DNA. The cell then attempts to repair the break. During this repair process, scientists can disrupt a gene, remove a section of genetic material, or introduce a desired change. This ability to make targeted genetic modifications has opened new possibilities for studying and treating genetic disorders.

One of the most promising applications of CRISPR is the treatment of inherited diseases. Some medical conditions are caused by mutations in a person’s genes, meaning that the underlying problems exist within their DNA. Rather than treating only the symptoms of these diseases, gene editing has the potential to address the genetic cause itself. Researchers have investigated CRISPR for conditions such as sickle cell disease and beta-thalassemia, which affect the body’s ability to produce healthy red blood cells.

CRISPR has already moved beyond laboratory research and into clinical medicine, IN 2023, regulatory authorities in the United Kingdom and the United States approved the first CRISPR-based treatments for sickle cell disease and transfusion-dependent beta-thalassemia. These treatments use a patient's own blood stem cells, which are collected and genetically modified outside the body before being returned to the patient. The development of these therapies demonstrated that gene editing can move from a scientific concept toward an actual medical treatment. 

However, CRISPR also presents significant challenges. One concern is off-target editing, where changes occur in parts of the genome that were not intended to be modified. Although scientists have developed methods to improve the accuracy of CRISPR, unintended genetic changes remain an important area of research. Scientists must carefully evaluate the safety and long-term effects of gene-editing treatments before they can be widely used.  

CRISPR also raises important ethical questions. There is a major distinction between editing somatic cells, which affects only the individual receiving treatment, and editing germline cells, which could pass genetic changes to future generations. Germline editing raises concerns about whether humans should be allowed to make permanent genetic changes that future generations cannot consent to. There are also concerns about unequal access to expensive gene-editing technologies and the possibility that genetic technologies could eventually be used for purposes beyond treating serious diseases.

Despite these challenges, CRISPR represents a major shift in medical science. Instead of simply managing certain genetic conditions, researchers are exploring whether it is possible to change the biological instructions responsible for disease. Continued research is needed to determine how safe, effective, and accessible these technologies can become. 

Ultimately, CRISPR gene editing demonstrates how rapidly technology is changing medicine. Its ability to precisely modify DNA has already contributed to new treatments and could eventually transform how numerous genetic conditions are managed. At the same time, its development must be accompanied by careful research, ethical discussion, and responsible regulation. CRISPR may not provide a solution to every genetic disease, but it has opened a new chapter in medicine by giving scientists an unprecedented ability to work directly with the genetic foundations of human health. 

Works Cited:

Brodhead, Andrew. What Is CRISPR? A Bioengineer Explains | Stanford Report, 10 June 2024, news.stanford.edu/stories/2024/06/stanford-explainer-crispr-gene-editing-and-beyond. Accessed 23 Aug. 2026.

“Gene Editing.” CRISPR Therapeutics, crisprtx.com/gene-editing. Accessed 23 Aug. 2026.

Shen, Shengfu, et al. “CRISPR as a Strong Gene Editing Tool.” BMB Reports, U.S. National Library of Medicine, Jan. 2017, pmc.ncbi.nlm.nih.gov/articles/PMC5319660. Accessed 23 Aug. 2026.

“What Are Genome Editing and CRISPR-Cas9?: Medlineplus Genetics.” MedlinePlus, U.S. National Library of Medicine, Mar. 2022,medlineplus.gov/genetics/understanding/genomicresearch/genomeediting/. Accessed 23 Aug. 2026.

(Image: BBC)

Alzheimer's disease is the most common cause of dementia, affecting more than 7 million Americans, and over 55 million people worldwide. Alzheimer’s disease causes lasting memory issues. It affects thinking and reasoning, making concepts like numbers difficult to grasp. Judgement and decisions are also influenced, making driving and cooking hard to manage. 

The changes that come with this disease usually start in the part of the brain that deals with learning. This can lead to symptoms like (but not limited to): disorientation, confusion, changes in mood, aggression, and even delusions. 

The cause of Alzheimer's is unknown but many scientists believe it has to do with a  combination of genetic, habitual, and environmental factors. The root of the issue has to do with brain proteins that don’t operate properly. This causes a disruption in the neurons, affecting how they work, leading to damage and a loss of connection with other neurons.

Scientists looking for the cause also focus on the role of two proteins, plaques and tangles. Beta-amyloid is a part of a larger protein that when clumped together forms larger deposits called amyloid plaques. These clumps are able to influence the communication between brain cells. Tangles are formed when tau proteins change shape. These can affect the transport system of nutrients and other important materials. 

Although the cause of Alzheimer’s disease isn’t fully known, a blood test is being developed to detect the early signs. It was recently FDA approved for people 55 and older that are experiencing mental decline.

However, this test does not diagnose Alzheimer's disease, it measures two proteins in the blood to determine whether amyloid plaque is present in the brain. A range is then provided to the doctors after the blood is sent to the lab. There’s a high-end cutoff, patients that place over it have over a 90% likelihood of having Alzheimer's disease, while those who score below are almost certain to not have it. However, other details about the patient need to be taken into consideration. Medical history, family history, and medication could all influence the results of the blood test.

For those eligible, this blood test can be ordered by a primary care provider. The patient is required to go to a lab for the test.

Prior to this discovery, a buildup in amyloid could be detected through PET scans or the analysis of cerebrospinal fluid. The issues with these are the cost, availability, and invasivity. In contrast, the blood test simply requires a blood draw, making it accessible and less invasive. 

Alzheimer’s disease affects more than 7 million Americans and over 55 million people worldwide. This disease can come with different complications like (but not limited to): confusion, memory loss, and an impairment in judgement. A blood test can help offer a fast, affordable, and less invasive method to identify brain changes linked to this disease. While the blood test is only recommended for those 55 and older, Alzheimer’s disease is constantly being researched to improve lives all around the world. 

Works Cited:

Alzheimer’s Association. “What Is Alzheimer’s Disease?” Alzheimer’s Association, 2025, https://www.alz.org/alzheimers-dementia/what-is-alzheimers. Accessed 13, Aug. 2026

“Alzheimer’s Blood Test Detects Early Stages of Disease.” Hopkinsmedicine.Org, 27 June 2025, https://www.hopkinsmedicine.org/health/treatment-tests-and-therapies/alzheimers-blood-test-detects-early-stages-of-disease. Accessed 13, Aug. 2026

Mayo Clinic. “Alzheimer’s Disease.” Mayo Clinic, Mayo Foundation for Medical Education and Research (MFMER), 8 Nov. 2024, https://www.mayoclinic.org/diseases-conditions/alzheimers-disease/symptoms-causes/syc-20350447. Accessed 13, Aug. 2026

Office. “FDA Clears First Blood Test Used in Diagnosing Alzheimer’s Disease.” U.S. Food and Drug Administration, 2025, https://www.fda.gov/news-events/press-announcements/fda-clears-first-blood-test-used-diagnosing-alzheimers-disease. Accessed 13, Aug. 2026

(Image: News Intervention)

When most people hear the word “vaccine,” they think about preventing diseases like the flu, COVID-19, or measles. Vaccines usually work by preparing the immune system to recognize and fight off viruses or bacteria before they cause illness. However, scientists are developing a completely different type of vaccine that does not prevent cancer from developing. Instead, these vaccines are designed to help the body fight cancer after it has already appeared.

Known as personalized cancer vaccines, this emerging technology creates treatments based on the unique characteristics of an individual patient’s tumor. Rather than giving every patient the same medication, doctors and researchers are working toward a future where cancer treatments can be customized for each person.

Cancer develops when cells accumulate genetic changes, or mutations, that cause them to grow uncontrollably. These mutations are different from person to person, meaning two patients with the same type of cancer may have tumors that behave differently. Personalized cancer vaccines use information from these mutations to train the immune system to identify and attack cancer cells more accurately.

The process begins by collecting a sample of a patient’s tumor. Scientists analyze the tumor’s DNA to identify specific mutations that create unusual proteins, called neoantigens, on the surface of cancer cells. These neoantigens act like markers that help the immune system distinguish cancer cells from healthy cells. Researchers then design a vaccine that teaches immune cells, especially T cells, to recognize those markers and target the cancer cells.

Unlike traditional cancer treatments such as chemotherapy, which can affect both healthy and cancerous cells, personalized cancer vaccines aim to make the immune response more targeted. The goal is to help the immune system fight cancer while reducing damage to normal tissues.

One of the most studied approaches involves mRNA technology, the same technology used in some COVID-19 vaccines. Instead of using a weakened virus, mRNA vaccines deliver instructions that tell cells how to produce a specific protein. In cancer vaccines, those instructions can teach the immune system what cancer markers to look for. Researchers are studying whether this approach can create stronger and longer-lasting immune responses against tumors.

Clinical trials are currently investigating personalized cancer vaccines for several types of cancer, including melanoma, pancreatic cancer, colorectal cancer, and other solid tumors. Some early studies have shown promising results, particularly when personalized vaccines are combined with other forms of immunotherapy. For example, researchers have been studying vaccines that work alongside immune checkpoint inhibitors, drugs that help remove barriers preventing immune cells from attacking cancer.

However, personalized cancer vaccines are not yet a standard treatment available to all cancer patients. Creating these vaccines is complex and requires advanced technology, genetic analysis, and time. Cancer is also constantly changing, and tumors can develop new mutations that allow them to escape immune attacks. Scientists are continuing to research how to make these vaccines faster, more effective, and available to more patients.

There are also questions about cost and accessibility. Personalized medicine requires specialized equipment and expertise, which could make treatments expensive. As these technologies develop, researchers and healthcare systems will need to consider how to ensure that new cancer treatments are not only innovative but also accessible.

Despite these challenges, personalized cancer vaccines represent a major shift in how scientists think about cancer treatment. For decades, cancer care has often relied on treatments designed for groups of patients. Personalized vaccines move medicine toward a more individualized approach, where a patient’s own biology helps guide their treatment.

The future of cancer care may not involve one universal cure, but rather thousands of personalized strategies designed for different patients and their unique tumors. While more research is needed before these vaccines become widely available, they represent an important step toward a future where the immune system becomes one of medicine’s most powerful tools against cancer.

Works Cited:

National Cancer Institute. “Cancer Treatment Vaccines.” National Cancer Institute, National Institutes of Health, https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/cancer-treatment-vaccines Accessed 25 July 2026.

National Cancer Institute. “mRNA Vaccines: A New Approach to Treating Cancer.” National Cancer Institute, National Institutes of Health, https://www.cancer.gov/news-events/cancer-currents-blog/2022/mrna-vaccines-to-treat-cancer. Accessed 25 July 2026.

Rojas, Luis A., et al. “Personalized RNA Neoantigen Vaccines Stimulate T Cells in Pancreatic Cancer.” Nature, vol. 618, 2023, pp. 144–150, https://doi.org/10.1038/s41586-023-06063-y. Accessed 25 July 2026.

Sahin, Uğur, et al. “Personalized Cancer Vaccines: A New Era of Cancer Immunotherapy.” Nature Medicine, vol. 29, 2023, https://www.nature.com/articles/s41591-023-02432-2. Accessed 25 July 2026.

(Image: Union for International Cancer Control - UICC)

Breast cancer is one of the most common cancers affecting women worldwide. Although men can also develop breast cancer, the disease is far more common in women. Researchers have identified several factors that can increase a person's risk of developing breast cancer. Understanding these risk factors can help individuals make informed decisions about their health and participate in appropriate screening programs.

One of the most significant risk factors for breast cancer is age. According to the Centers for Disease Control and Prevention (CDC), most breast cancer cases are diagnosed in women over the age of 50. As people grow older, changes in cells become more likely, increasing the chance that cancer may develop. While younger women can also develop breast cancer, the risk generally increases with age.

Genetics and family history also play an important role. Women who inherit mutations in certain genes, particularly BRCA1 and BRCA2, have a much higher risk of developing breast cancer during their lifetime. In addition, individuals with close family members, such as a mother, sister, or daughter, who have had breast cancer are more likely to develop the disease themselves. A family history of ovarian cancer can also increase breast cancer risk.

Certain reproductive factors have been linked to breast cancer as well. Women who begin menstruation before age 12 or experience menopause after age 55 are exposed to estrogen and other hormones for a longer period of time. This extended hormone exposure may increase the likelihood of breast cancer. Women who have their first child after age 30, never have a full-term pregnancy, or do not breastfeed may also face a higher risk.

Lifestyle choices can significantly affect breast cancer risk. Physical inactivity and obesity, especially after menopause, are associated with a greater chance of developing breast cancer. Maintaining a healthy weight and engaging in regular exercise can help lower this risk. Alcohol consumption is another important factor. Studies have shown that breast cancer risk increases as alcohol intake increases.

Medical history can also contribute to breast cancer risk. Women who have previously been treated with radiation therapy to the chest area, particularly before age 30, are more likely to develop breast cancer later in life. Additionally, women who have had breast cancer before or certain noncancerous breast conditions may be at greater risk of developing the disease again.

Although some risk factors, such as age and genetics, cannot be changed, many lifestyle-related factors can be controlled. Regular physical activity, maintaining a healthy body weight, limiting alcohol consumption, and discussing hormone therapies with a healthcare provider can help reduce the risk of breast cancer. Early detection through regular screenings, such as mammograms, also improves the chances of successful treatment.

In conclusion, breast cancer is influenced by a combination of genetic, hormonal, medical, and lifestyle factors. While no one can completely eliminate their risk, understanding these factors can help individuals make healthier choices and seek appropriate medical care. Increased awareness and preventive measures continue to play a critical role in reducing the impact of breast cancer on society.

Works Cited:

"Breast Cancer Risk Factors." Centers for Disease Control and Prevention, 15 Apr. 2026, https://www.cdc.gov/breast-cancer/risk-factors/index.html. Accessed 18 June 2026.

"Breast Cancer Awareness." Centers for Disease Control and Prevention, 30 July 2025, https://www.cdc.gov/cancer/features/breast-cancer.html. Accessed 18 June 2026.

"Reducing Risk for Breast Cancer." Centers for Disease Control and Prevention, 11 Sept. 2024, https://www.cdc.gov/breast-cancer/prevention/index.html. Accessed 18 June 2026.

(Image: ENT Specialists of the Rockies)

Imagine a cochlear implant that works without any visible external equipment, a clean and sleek totally implantable cochlear where the possibility of it falling off or getting caught on something is removed. In current technology standard cochlear implants (CIs) are partially implantable consisting of two components, the one worn outside the body which acts as an external transmitter and one placed inside the ear during surgery which is the internal receiver. A magnet is what holds the external transmitter to the internal receiver which then sends electrical signals to the electrode array connected to the cochlea allowing people with profound hearing loss to experience speech and sounds. 

However the use of the standard partially implantable cochlear implants have well documented limitations, one of the most common being the vulnerability of the external processors to physical and water damage. Traditional CI’s cannot be worn while sleeping which could potentially create an unsafe situation for the user, and the daily cleaning of the CIs and replacing of the batteries can be tedious and difficult, especially when a user is elderly and has dexterity issues. 

All of these limitations is why researchers have come up with trials and testing for a completely implantable CI. These are called TICI’s or Totally Implantable Cochlear Implants, and they are potentially the next generation of cochlear implants which eliminate some of the struggles that partial CI users have. TICI’s allow for 24/7 continuous hearing because they are internal there is less exposure to damage with no need to take them off at night or during showers as there is no water damage concern. Cosmetically as well TICI’s can be an easier way for users to avoid the stigma around appearing deaf, it allows them to avoid unnecessary attention and bothersome questions and control when they want people to be aware of their condition. This feature particularly can be very attractive towards younger CI users who might feel the impacts of more extreme impact or bullying because of their CI. 

Despite all the benefits of TICI’s there are still drawbacks which is the reason why they are tentatively being put into clinical trials. One of these drawbacks is Microphone Attenuation which refers to the microphones tendency to pick up internal body noises such as a heartbeat, chewing etc… because it’s embedded inside the body, this can lead to disproportionate signal to noise ratio and potential discomfort for the user. Additionally the power and battery constraints of the internal battery only being able to charge with a biocompatible charger which remains a technological challenge for researchers and a currently tedious task for users of TICI’s in clinical trials. The eligibility for TICI use is also a smaller range than for CI users with the technology primarily relying on the middle ear anatomy being viable with abnormalities completely disqualifying a patient from TICI’s with the current models. There are also issues if the processor or hardware part of the TICI dies or malfunctions like technologies tend to do surgery is required to replace the hardware rather than the much easier process of swapping external hardware one might see with CI’s. 

Overall the advancement of the TICI is an important step in progress toward improving existing solutions to widespread health problems, it’s a viable solution for many of the limitations that surround the current technology for the CI’s and could potentially become a replacement for the current technology or at the very least lead to new roads in the new technology. 

Works Cited:

Lefebvre, Philippe, and Joachim Müller. “The Totally Implantable Cochlear Implant.” ENT & Audiology News, 4 Sept. 2025, www.entandaudiologynews.com/features/ent-features/post/the-totally-implantable-cochlear-implant. Accessed 16 May 2026.

“Step toward Fully Implantable Cochlear Implants.” Columbia Engineering, Columbia University, www.engineering.columbia.edu/about/news/step-toward-fully-implantable-cochlear-implants. Accessed 16 May 2026.

“Cochlear Implants.” Mayo Clinic, www.mayoclinic.org/tests-procedures/cochlear-implants/about/pac-20385021. Accessed 17 May 2026.

(Image: HSS)

In today’s, high pressure environment, stress has become an almost unavoidable part of adolescence. From academic expectations to social pressures that are amplified by digital media, teenagers are experiencing sustained levels of stress at increasingly younger ages. While stress is often dismissed as a normal part of growing up, medical research suggests that chronic stress does far more than affect mood for a small period of time,it can physically reshape the developing teenage brain. From a neurological and medical standpoint, this trend raises serious concerns about long term cognitive and emotional health.

One of the most significant biological mechanisms behind stress is the activation of the hypothalamic pituitary adrenal (HPA) axis, which regulates the body’s stress response. When a teen experiences stress, the body releases cortisol, a hormone designed to help manage short-term threats. However, during adolescence (which is a period marked by rapid brain development) this system becomes especially reactive. Studies show that teens exhibit heightened hormonal responses to stress, making their brains more vulnerable to its effects.

Chronic exposure to elevated cortisol can lead to structural changes in key brain regions. The hippocampus, which is responsible for memory and learning, and the prefrontal cortex, which governs decision making and impulse control, are particularly affected. Research indicates that prolonged stress can reduce the complexity and size of neurons in these areas, impairing cognitive functions such as memory retention and attention. At the same time, the amygdala, the brain’s emotional center may become more active or even grow, increasing fear responses and emotional reactivity. This imbalance can leave teenagers more prone to anxiety, mood disorders, and difficulty regulating emotions.

Beyond structural changes, chronic stress can also interfere with the brain’s development at a cellular level. During adolescence, the brain undergoes significant neural pruning and strengthening of connections, processes essential for efficient thinking and behavior. However, stress disrupts this process by reducing neurogenesis (the formation of new neurons) and weakening synaptic connections. Additionally, research suggests that stress may delay the maturation of the prefrontal cortex, the region responsible for higher order thinking and self control. This delay can manifest in poorer decision-making, reduced impulse control, and increased risk taking behaviors.

Perhaps most concerning is that the effects of stress during adolescence may be long lasting or even permanent. While adult brains often recover from stress related changes, studies indicate that stress experienced during adolescence can produce alterations that persist well into adulthood. This is because the teenage brain is still forming its foundational structures, making it more susceptible to environmental influences. As a result, chronic stress during this critical period is linked to an increased risk of mental health disorders such as depression, anxiety, and substance abuse later in life.

Despite these risks, not all stress is harmful. Short term or “acute” stress can enhance focus and resilience, this is called Eustress in psychology and its main purpose is helping people adapt to challenges. The problem arises when stress becomes constant and overwhelming, preventing the brain from returning to its baseline state. From a medical perspective, this distinction is crucial: the goal is not to eliminate stress entirely, but to prevent it from becoming chronic and damaging.

Overall, chronic stress is not merely an emotional burden for teenagers, it’s a biological force capable of reshaping the brain itself. By altering brain structure, disrupting development, and increasing vulnerability to mental illness, prolonged stress poses a significant threat to adolescent health. Recognizing these effects underscores the importance of early intervention, stress management, and supportive environments. As society continues to place increasing demands on young people, addressing chronic stress is not just a psychological necessity but a medical imperative. 

Works Cited:

Eiland, L, and R D Romeo. “Stress and the developing adolescent brain.” Neuroscience vol. 249 (2013): 162-71. doi:10.1016/j.neuroscience.2012.10.048. Accessed 10 April. 2026

American Psychological Association. (2024, October 22). How to help children and teens manage their stress. https://www.apa.org/topics/children/stress. Accessed 10 April 2026

National Scientific Council on the Developing Child (2005/2014). Excessive Stress Disrupts the Architecture of the Developing Brain: Working Paper No. 3. Updated Edition. Retrieved from www.developingchild.harvard.edu. Accessed 10 April 2026

(Image: VitAL Alabama)

  In the health industry opioids such as morphine and oxycodone have been the most accessible and powerful tools for doctors treating severe pain. However the major drawback of this is the high risk of addiction and overdose, which have created the opioid crisis as a result. In response to this crisis scientists have developed safer alternatives to pain management. One of the newest and most promising of these developments is a drug called suzetrigine, its brand name being Journavx.

Suzetrigine is a newly approved prescription medication designed to treat moderate to severe acute pain, particularly after surgery or injury. In January 2025, the U.S. Food and Drug Administration (FDA) approved it as the first drug in a completely new class of painkillers in over 20 years.Unlike traditional opioids, which act on receptors in the brain to dull the perception of pain and often trigger feelings of euphoria, suzetrigine operates through a fundamentally different mechanism. 

It targets specific sodium channels, known as NaV1.8 channels, located in peripheral nerves. These channels play a crucial role in transmitting pain signals from the site of injury to the brain. By blocking these pathways, suzetrigine prevents pain signals from ever reaching the brain, rather than altering the brain’s response to them. This distinction is essential because it eliminates the activation of reward pathways that are responsible for addiction, making the drug a safer alternative for patients requiring short term pain relief.

The effectiveness of suzetrigine has been demonstrated in clinical trials, particularly for patients experiencing moderate to severe acute pain following surgical procedures. In these settings, the drug has shown pain relieving capabilities comparable to some opioid medications, offering a viable substitute without the associated risks of dependency or overdose. This makes it especially valuable in post-operative care, where managing pain is essential for recovery but must be balanced against the potential for long term harm. Additionally, because suzetrigine does not depress the central nervous system, it avoids dangerous side effects such as respiratory suppression, a leading cause of opioid related deaths.

Despite its promise, suzetrigine is not without limitations. Its current use is largely restricted to short-term, acute pain, and its effectiveness for chronic pain conditions remains uncertain. Chronic pain often involves more complex neurological processes that may not be fully addressed by blocking peripheral nerve signals alone. Furthermore, while the drug is considered safer than opioids, it can still produce mild side effects, including skin irritation and muscle discomfort. These factors indicate that while suzetrigine is a significant advancement, it is not a comprehensive solution to all pain management challenges.

Nevertheless, the development of suzetrigine signals an important transition in medical research and treatment strategies. It reflects a growing emphasis on targeting the biological origins of pain rather than relying on broad, system wide suppression of symptoms. As additional non-opioid medications are developed, this approach has the potential to transform how pain is treated, reducing dependence on opioids and mitigating the public health risks they pose. 

Works Cited:

“FDA Approves Novel Non-Opioid Treatment for Moderate to Severe Acute Pain.” U.S. Food and Drug Administration  www.fda.gov/news-events/press-announcements/fda-approves-novel-non-opioid-treatment-moderate-severe-acute-pain  Jan. 2025. Accessed 24 Mar. 2026.

“Journavx: Long-Awaited Non-Opioid Treatment for Acute Pain Hits Market.” UCHealth Today, www.uchealth.org/today/journavx-long-awaited-non-opioid-treatment-for-acute-pain-hits-market/  2025. Accessed 23 Mar. 2026.

(Image: Apollo Scientific)

In recent years, scientists have begun exploring an idea that once seemed impossible: bringing extinct species back to life. This process, known as de-extinction, relies on modern genetic technology and ancient DNA research. One species that has captured both scientific and public attention is the Dire Wolf (Aenocyon dirus), this creature is a massive Ice Age predator that once roamed North America but disappeared roughly 10,000 years ago. Although reviving such a species might initially seem like a project focused only on ecology or curiosity about the past, the technologies developed through de-extinction research may also lead to important medical breakthroughs. By improving genetic engineering, revealing ancient disease adaptations, and advancing regenerative biology, efforts to bring back dire wolves could contribute to major developments in modern medicine.

The dire wolf was one of the most formidable predators of the late Ice Age. Larger and more heavily built than modern wolves, dire wolves likely hunted large prey such as bison and ancient horses. Fossil discoveries show that they were widespread throughout North and South America, and thousands of their remains have been found preserved at the La Brea Tar Pits in California. Despite their success as predators, dire wolves eventually went extinct near the end of the last Ice Age, likely due to a combination of climate change and the disappearance of many large prey species. Although the animal itself vanished, its fossilized bones still contain fragments of DNA that researchers can analyze today.

The possibility of de-extinction depends on reconstructing this ancient DNA and using it to recreate the genome of the extinct species. Scientists compare recovered genetic material with the DNA of closely related animals and attempt to fill in missing segments. One of the most powerful tools in this process is CRISPR Gene Editing, a technology that allows scientists to precisely modify DNA sequences. Using CRISPR, researchers can alter the genome of a living relative—such as the Gray Wolf—so that it contains the genetic traits associated with the extinct species. Although many technical and ethical challenges remain, this research represents a major step forward in the ability to manipulate and understand complex genomes.

While the goal of de-extinction may be to recreate lost species, the technologies developed during this research have significant medical implications. First, the process requires extremely precise genetic engineering. Scientists must identify which genes produce specific physical traits and how they interact within an organism. Improving these techniques could make it easier to repair harmful genetic mutations in humans. Many inherited disorders result from small errors in DNA sequences, and the same editing tools used to reconstruct ancient genomes could potentially be adapted to correct these mutations in patients.

Another area where de-extinction research could contribute to medicine is the study of ancient disease resistance. Species that lived during harsh prehistoric climates often evolved unique biological adaptations to survive environmental stress and pathogens. By analyzing the genetic traits preserved in extinct animals, scientists may discover new insights into how immune systems respond to disease. These findings could eventually help researchers design treatments or preventative strategies for modern illnesses.

The work required to recreate extinct species also overlaps heavily with fields such as cloning, stem cell research, and Regenerative Medicine. In order to bring an extinct animal to life, scientists must learn how to grow and manipulate cells so that they develop into a complete organism. Techniques developed through this process may eventually help doctors repair damaged tissues or grow replacement organs. For example, improved control over stem cell development could make it possible to regenerate skin, muscle, or even internal organs for patients suffering from injuries or degenerative diseases.

Beyond direct medical treatments, the study of extinct species may also lead to discoveries that influence pharmaceutical development. Ancient organisms sometimes contain genetic pathways or biological mechanisms that differ from those found in modern animals. By studying these differences, researchers may uncover new proteins or biochemical processes that could inspire innovative drugs or therapies. Even if the dire wolf itself is never fully revived, the knowledge gained from attempting to reconstruct its biology could still influence biotechnology research for decades.

Despite these promising possibilities, the idea of de-extinction also raises important ethical and scientific questions. Some researchers argue that reviving extinct species could disrupt modern ecosystems or divert resources away from protecting endangered animals that still exist today. Others question whether recreated animals could truly thrive in environments that have changed dramatically since their extinction. These debates highlight the complexity of balancing scientific innovation with ecological responsibility.

Works Cited: 

“CRISPR Gene Editing.” National Human Genome Research Institute, U.S. Department of Health and Human Services, https://www.genome.gov/about-genomics/policy-issues/CRISPR. Accessed 8 Mar. 2026.

“Dire Wolf (Aenocyon dirus).” Smithsonian National Museum of Natural History, Smithsonian Institution, https://naturalhistory.si.edu. Accessed 8 Mar. 2026.

“Dire Wolf.” Encyclopaedia Britannica, Encyclopaedia Britannica, Inc., https://www.britannica.com/animal/dire-wolf. Accessed 8 Mar. 2026.

“Gray Wolf.” National Geographic, National Geographic Society, https://www.nationalgeographic.com/animals/mammals/facts/gray-wolf. Accessed 8 Mar. 2026.

“Regenerative Medicine.” National Institutes of Health, U.S. Department of Health and Human Services, https://stemcells.nih.gov/info/basics/regenerative-medicine. Accessed 8 Mar. 2026.

“Tar Pits and Ice Age Fossils.” La Brea Tar Pits and Museum, https://tarpits.org. Accessed 8 Mar. 2026. 

(Image: Vital Record - Texas A&M University)

The shortage of donor organs remains a critical challenge in modern medicine. Thousands of patients worldwide wait for life-saving transplants, many of whom never receive suitable organs in time due to waitlists and the sheer demand of organs. As a result of this, regenerative medicine has emerged as a particularly necessary research focused on growing organs from stem cells. This new technology has the potential to transform transplantation medicine, disease treatment, and biomedical research.

To understand this new technology defining stem cells is key, Stem cells are unique cells capable of self-renewal and differentiation into specialized cell types. There are several major categories of stem cells but the two most relevant are Embryonic stem cells and Adult stem cells. Embryonic stem cells can develop into nearly any cell type in the body and therefore have a property of being pluripotent. Adult stem cells are more limited but play an important role in tissue repair and maintenance. Induced pluripotent stem cells (iPSCs) represent a major scientific breakthrough, as they are created by reprogramming adult cells into a pluripotent state, allowing researchers to generate patient-specific tissues without relying on embryonic sources.

The primary motivation for growing organs in vitro is to address transplant shortages and reduce organ rejection. Traditional organ transplantation often requires immunosuppressive drugs to prevent immune system attacks on donated organs. Lab-grown organs derived from a patient’s own cells could significantly reduce rejection risks. Additionally, stem cell organ technology provides ethical alternatives to traditional donation systems and offers new opportunities for pharmaceutical testing and personalized medicine.

Scientists use several advanced methods to grow organs from stem cells. Directed differentiation allows researchers to guide stem cells into becoming specific cell types by exposing them to controlled chemical and biological signals. Three-dimensional bioprinting is another important innovation, enabling scientists to construct tissue structures layer by layer using cell-based bio-inks. Researchers also develop organoids, which are small, simplified versions of organs grown in laboratory conditions. Although organoids do not fully replicate complete organ function, they are valuable models for studying disease and drug responses. Another technique involves decellularization, where cells are removed from donor organs, leaving behind structural scaffolds that can be repopulated with stem cells.

Significant progress has already been achieved in regenerative medicine. Scientists have successfully created lab-grown skin for burn treatment and engineered replacement tissues for structures such as the trachea and bladder. Additionally, organoid models of the heart, brain, and kidneys are widely used in biomedical research and clinical testing.

Despite these advancements, several challenges remain. One major obstacle is vascularization, or the formation of functional blood vessel networks within lab-grown organs. Without proper blood supply, engineered organs cannot survive after transplantation. Safety concerns also exist, including the potential for uncontrolled cell growth and tumor formation. Furthermore, the high cost of stem cell therapies limits widespread clinical accessibility.

Ethical considerations continue to shape stem cell research. Debates surrounding embryonic stem cell use have encouraged the development of alternative methods such as iPSCs. Regulatory agencies continue to establish guidelines to ensure safe and ethical research practices.

Future advancements in gene editing and developmental biology may further accelerate progress in organ engineering. If these technologies continue to develop successfully, stem cell-based organ production could dramatically reduce transplant waitlists and improve global healthcare outcomes.

In conclusion, stem cell-based organ engineering represents a major advancement in regenerative medicine. Although scientific and ethical challenges remain, continued research may make lab-grown organs a viable medical solution in the future.

Works Cited: 

Mayo Clinic Staff. “Stem Cells: What They Are and What They Do.” Mayo Clinic, 21 Jan. 2026, https://www.mayoclinic.org/tests-procedures/bone-marrow-transplant/in-depth/stem-cells/art-20048117.  Accessed 18 Feb. 2026.

Yamanaka, Shinya. “Induced Pluripotent Stem Cells: Past, Present, and Future.” Cell Stem Cell, 14 June 2012, vol. 10, no. 6, pp. 678–684, https://doi.org/10.1016/j.stem.2012.05.005.  Accessed 19 Feb. 2026.

National Institute of General Medical Sciences. What Are Stem Cells? 27 Nov. 2024, https://nigms.nih.gov/biobeat/2024/11/what-are-stem-cells . Accessed 20 Feb. 2026.

NIH Stem Cell Information. Stem Cell Basics. n.d., https://stemcells.nih.gov/info/basics/stc-basics. Accessed 20 Feb. 2026.

National Institute of Health. Stem Cells and Regenerative Medicine. 9 May 2025, https://orip.nih.gov/division-comparative-medicine/initiatives/stem-cells-and-regenerative-medicine . Accessed 21 Feb. 2026.

(Image: Prowers Medical Center)

Breast cancer screenings saves lives yet like many Breast cancer screening saves lives, but reading mammograms isn’t perfect. Radiologists can miss small signs or flag normal tissue by mistake, which brings stress and unnecessary procedures for patients. That’s where AI is starting to help.

Even with better imaging tech, mistakes still happen: false alarms, missed cancers, and results that vary from one reader to the next. False positives mean extra biopsies, while false negatives can push treatment back. Radiologist workload and varying interpretations make the problem tougher, so tools that boost accuracy and consistency are welcome.

AI steps in by crunching imaging data faster and spotting patterns that humans might miss. These systems learn from thousands of mammograms, picking up subtle cues that could signal cancer. With machine learning and deep learning, the software keeps getting better as more data rolls in.

Research shows AI-assisted mammography can raise cancer detection rates and cut down on unnecessary follow-ups. It’s especially good at spotting cancers in dense breast tissue, where traditional screening struggles. By flagging suspicious areas, AI helps radiologists make more informed calls.

Far from replacing radiologists, AI acts like a helpful second pair of eyes that supports decision-making and eases fatigue. In practice, it can triage cases, flag urgent findings, and offer consistent assessments, letting radiologists focus on the toughest cases. The collaboration plays to the strengths of both people and machines.

There’s growing clinical evidence that AI-enhanced readings perform as well as—or better than—traditional methods in accuracy and efficiency. Several trials have reported higher detection rates and fewer unnecessary recalls when AI is part of screening programs. Hospitals adopting AI often see smoother workflows and steadier diagnoses.

As AI becomes more common in breast cancer screening, it’s important to handle ethics, regulation, and implementation thoughtfully. Protecting data privacy, avoiding biases in training data, and securing regulatory approvals are all crucial for safe, fair use. Datasets need to be diverse and representative to work well across different populations.

Ongoing research points to a future with even smarter mammography: personalized screening, multi-imaging approaches, and smarter diagnostics. The goal is to combine mammograms with other imaging methods, genetic information, and patient history to tailor recommendations and push earlier detection even further.

Overall, AI is boosting accuracy, consistency, and efficiency in mammography. As technology evolves, the teamwork between AI and radiologists holds the promise of better outcomes for patients, fewer unnecessary procedures, and earlier, more reliable detection.

Works Cited: 

Chang, Yun‑Woo, et al. “Artificial Intelligence for Breast Cancer Screening in Mammography (AI‑STREAM): Preliminary Analysis of a Prospective Multicenter Cohort Study.” Nature Communications, vol. 16, no. 2248, 6 Mar. 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC11885569/ . Accessed 19 Jan. 2026.

“Mammograms.” National Cancer Institute, 2 Dec. 2025, https://www.cancer.gov/types/breast/screening/mammograms . Accessed 19 Jan. 2026.

“Mammogram: What It Is, Purpose, Procedure, Results & Types.” Cleveland Clinic, 17 Oct. 2024, https://my.clevelandclinic.org/health/diagnostics/4877-mammogram  . Accessed 19 Jan. 2026.

“How AI Helps Make Your Mammogram Smarter.” Lakewood Health System, 2026, https://www.lakewoodhealthsystem.com/how-ai-helps-make-your-mammogram-smarter/ . Accessed 19 Jan. 2026.

Google Search Results for “AI improves accuracy in mammograms”. Google, https://www.google.com/search?q=AI+improves+accuracy+in+mammograms . Accessed 19 Jan. 2026.

(Image: Sleep Review)

Oura Rings are part of a growing wave of health technology designed to make tracking your body feel simple and almost invisible. Instead of wearing a watch or carrying a device, users wear a smooth, lightweight ring on their finger that quietly collects health data throughout the day and night. While Oura Rings are often marketed as wellness tools rather than medical devices, they have still sparked serious conversations in the medical and scientific world about how reliable consumer health technology really is.

At its core, an Oura Ring is a biometric tracker. Inside the ring are tiny sensors that measure heart rate, heart rate variability, body temperature changes, breathing rate, blood oxygen levels, movement, and sleep stages. The ring uses light-based sensors that detect blood flow through the finger, which is actually one of the most accurate places on the body to collect this type of data. All of this information syncs to an app, where it is turned into daily scores focused on sleep, readiness, and activity.

The main purpose of the Oura Ring is not to diagnose illness, but to help users notice patterns. If someone consistently sleeps poorly, feels run down, or shows unusual changes in body temperature or heart rate, the ring may highlight those shifts. For many users, this kind of feedback encourages better sleep habits, rest days, or stress management. Unlike many fitness trackers, Oura focuses more on recovery and long-term health trends rather than step counts or workout intensity alone.

Oura first entered the market in 2015 through crowdfunding, gaining attention for its minimalist design and focus on sleep science. As wearable technology became more popular, Oura stood out by prioritizing comfort and continuous wear, especially overnight. Over time, professional athletes, researchers, and everyday users helped push the product into the mainstream. During the COVID-19 pandemic, Oura gained even more attention when researchers explored whether temperature changes tracked by the ring could help identify early signs of illness, though this research was experimental and not diagnostic.

When it comes to credibility, the medical community tends to view Oura Rings as useful but limited. Studies have shown that Oura’s heart rate and sleep tracking are fairly accurate when compared to clinical tools, especially for trends over time rather than exact numbers. Doctors and researchers often agree that wearable data can be helpful for understanding sleep quality and recovery, but they also stress that no consumer wearable should replace medical testing or professional evaluation.

It is also important to note that Oura Rings are not FDA-approved medical devices. They are classified as general wellness products, meaning they are designed to support healthy habits rather than detect or treat disease. This distinction matters, especially for teens, because it sets clear boundaries on what the ring can and cannot do. A low readiness score or temperature change does not automatically mean someone is sick, and relying on the ring alone could lead to unnecessary worry.

Overall, Oura Rings represent how far personal health technology has come. They can help users become more aware of their bodies, routines, and recovery in a way that feels approachable and non-intrusive. As long as users understand their limits and treat the data as informational rather than medical advice, Oura Rings can be a useful addition to modern wellness rather than a replacement for real healthcare.

Works Cited: 

Business Wire. “Study from Top U.S. Hospital Finds Oura Ring Most Accurate Consumer Sleep Tracker Tested in Four-Stage Sleep Classification.” Business Wire, 10 Oct. 2024, www.businesswire.com/news/home/20241010549704/en/Study-from-Top-US-Hospital-Finds-Oura-Ring-Most-Accurate-Consumer-Sleep-Tracker-Tested-in-Four-Stage-Sleep-Classification. Accessed 30 Dec. 2025.

Oura Health. “2024 Sensors: Oura Ring Validation Study.” Oura Ring Blog, ouraring.com/blog/2024-sensors-oura-ring-validation-study/. Accessed 30 Dec. 2025.

Oura Health. “Oura Ring Accuracy Validation Study with the University of Tokyo.” Oura Ring Blog, ouraring.com/blog/oura-ring-accuracy-validation-study-university-of-tokyo/. Accessed 30 Dec. 2025.

Oura Health. “Science and Research.” Oura Ring, ouraring.com/science-and-research. Accessed 30 Dec. 2025.

Oura Health. “Product Safety and Use.” Oura Support, support.ouraring.com/hc/lv/articles/360025428394-Product-Safety-amp-Use.  Accessed 30 Dec. 2025.

U.S. National Library of Medicine. “Accuracy of the Oura Ring for Measuring Sleep and Heart Rate Metrics.” PubMed, pubmed.ncbi.nlm.nih.gov/35622397/. Accessed 30 Dec. 2025. PubMed, pubmed.ncbi.nlm.nih.gov/35622397/. Accessed 30 Dec. 2025.

U.S. National Library of Medicine. “Evaluation of Oura Ring Sleep Stage Classification Performance.” PubMed, pubmed.ncbi.nlm.nih.gov/39460013/.  Accessed 30 Dec. 2025.

U.S. National Library of Medicine. “Wearable Ring Technology for Long-Term Health Monitoring.” PubMed, pubmed.ncbi.nlm.nih.gov/40108409/.  Accessed 30 Dec. 2025.

(Image: LinkedIn)

Artificial intelligence (AI) is rapidly beginning to transform many industries, including healthcare, where it is playing an increasingly important role in medical diagnostics which is the process of identifying diseases and medical conditions. By analysing medical data quickly and accurately, AI has the potential to improve the healthcare system; however, its use in diagnostics also comes with ethical risks.

Currently, one of the most common applications of AI is in medical imaging. AI is used to analyse X-rays, CT scans, and MRIs in order to detect abnormalities such as malignant tumors, fractures, or other signs of disease or injury. AI is beneficial in imaging because it can reduce human error. Doctors who review scans multiple times a day are more prone to mistakes due to fatigue, and AI helps reduce that risk. AI can also process larger amounts of medical data, increasing efficiency for doctors treating patients and allowing small patterns in data to be identified and addressed accordingly.

Although the use of AI in diagnostics has many advantages and may seem like the most efficient way to diagnose patients, there are still many concerns. A major concern is the quality of AI systems. The accuracy of diagnostic AI depends heavily on the data on which it is trained, which can lead to bias and inaccurate results if the data is incomplete or unrepresentative. Moreover, many medical professionals question how AI systems are trained and what data is used. Medical data is sensitive and difficult to obtain, and AI systems raise concerns about protecting patient privacy, especially when companies prioritize efficiency or profit over patient trust.

Following this line of reasoning, many medical professionals also raise legal and ethical questions regarding the use of AI and patients’ sensitive medical data. Doctors value patient trust and consent above AI systems and therefore will always review and confirm diagnoses made by AI.

It is still too early to determine whether AI in diagnostics is ultimately more beneficial or harmful. While experimentation with AI in medicine is becoming more common, testing, regulations, and guidelines remain strict before AI can be fully implemented in medical settings. It is important to remember the role of healthcare professionals in this process: they are not being replaced by AI, but rather assisted by it. Doctors retain full control over final decisions about patient care and prioritize effective and ethical treatment.

Overall, it is clear that AI has the potential to significantly improve medical diagnostics by enhancing accuracy and accessibility. While challenges related to ethics, data quality, and patient trust remain, careful development and responsible use of AI can make it a valuable tool for doctors to support and confirm diagnoses. Continued research and collaboration between technology experts and healthcare professionals will help advance the healthcare industry and move it forward.

Works Cited

Al-Antari, Mugahed A. "Artificial Intelligence for Medical Diagnostics-Existing and Future AI Technology!." Diagnostics (Basel, Switzerland) vol. 13,4 688. 12 Feb. 2023, doi:10.3390/diagnostics13040688. Accessed 24 Dec. 2025.

"Artificial Intelligence (AI) in Health Care." Congress.gov, Library of Congress, 26 December 2025, https://www.congress.gov/crs-product/R48319 . Accessed 24 Dec. 2025.

Dmulford. "AI in Higher Education: A Meta Summary of Recent Surveys of Students and Faculty." Campbell Academic Technology Services, 6 Mar. 2025, sites.campbell.edu/academictechnology/2025/03/06/ai-in-higher-education-a-summary-of-recent-surveys-of-students-and-faculty/ . Accessed 24 Dec. 2025.